Molecular Diagnostics - BIORI Biotech

Pharmacogenomic Testing Reagent Strategy for Clinical Diagnostics

Foundation Medicine’s new collaboration with Fulgent Genetics highlights rising clinical demand for pharmacogenomic testing. This guide explains reagent, QC and OEM considerations for diagnostic teams.

cfDNA MRD Testing Reagent Strategy for Molecular Diagnostics

cfDNA MRD testing reagent and QC guide cover illustration

CareDx’s Naveris acquisition highlights rising interest in cfDNA MRD testing. This guide explains reagent, assay QC, sample prep and OEM considerations for molecular diagnostics teams.

IVD Reagent Quality Documentation for OEM Programs

IVD reagent quality documentation OEM guide with batch records QC reports CoA and traceability visuals

New FDA Form 483 response guidance highlights documentation discipline. This guide explains what IVD reagent OEM teams should prepare for QC, CoA and traceability.

Automated IVD Reagents for Respiratory Panels: QC and OEM Lessons

Automated IVD reagents for respiratory panels with nucleic acid extraction PCR reagents and QC workflow

Applied BioCode’s new FDA-cleared KingFisher extraction workflow for its respiratory panel highlights why automated IVD reagents need robust QC, OEM documentation and platform compatibility.

NGS Sample Preparation for Molecular Diagnostics: Reagent Strategy and QC

NGS Sample Prep Reagent Strategy and QC blog cover

A practical guide to NGS sample preparation for molecular diagnostics, covering input QC, library prep reagent selection, workflow consistency, and OEM considerations.

Biori Biotech to Exhibit at Lab Indonesia 2026

Biori Biotech will participate in Lab Indonesia 2026 at Booth 5D37, presenting innovative products and services for life science research, biotherapeutic analytical workflows, and molecular diagnostic product development.